Navigation Links
Former Patent Office Solicitor and Judge Joins Rothwell Figg
Date:1/10/2008

Nancy Linck Extends Firm's Life Sciences Capabilities

WASHINGTON, Jan. 10 /PRNewswire/ -- Rothwell, Figg, Ernst & Manbeck, P.C. announced today that Dr. Nancy J. Linck will join the firm in an Of Counsel position, effective Feb. 4, 2008. Dr. Linck has served as the former Solicitor and later an Administrative Patent Judge at the U.S. Patent & Trademark Office (USPTO), former Deputy General Counsel, IP & Trade, for the Biotechnology Industry Organization (BIO), and Senior Vice President, Intellectual Property and Regulatory Affairs and Chief Compliance Counsel, for Guilford Pharmaceuticals.

Dr. Linck commented that, "Rothwell, Figg, Ernst & Manbeck will provide an exceptional environment for me to return to private practice, and I am delighted to join what I have long regarded as one of the nation's leading intellectual property law firms."

"Rothwell Figg has, over many years, developed a strong biotechnology and pharmaceutical practice, and Nancy's extensive intellectual property expertise in these fields will help us expand our reach and continue to offer excellent service to our clients in these industries," Tony Figg of Rothwell, Figg, Ernst & Manbeck, P.C. said. "Nancy is one of the country's top IP lawyers, and her experience in private and corporate practice, as a frequent advocate for the USPTO in the Federal Circuit, and as a member of the Board of Patent Appeals and Interferences puts her in an extraordinary position to represent and counsel clients in a wide range of capacities."

The addition of Dr. Linck to the Rothwell Figg team is particularly timely in light of upcoming changes in the pharmaceutical and biotechnology markets. An estimated $29 billion worth of pharmaceutical patents are set to expire in the next two years, which will likely result in an increase in patent disputes as companies attempt to protect or extend their patents. Rothwell Figg will be well-positioned to advise companies on these matters.
'/>"/>

SOURCE Rothwell, Figg, Ernst & Manbeck, P.C.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
3. David Barker, Former Illumina CSO, Joins GenVaults Scientific Advisory Board
4. Former Pfizer Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics Inflammatory Disease Initiatives
5. Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant
6. Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors
7. Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists
8. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
9. Pressure BioSciences, Inc. Issued First Patent in Canada
10. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
11. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...hTrianglePark-basedCnanozInc.unveiledthefirstenerg...mNanoPure(TM)developedfromcarbonnanotubestoAndhraP...arupandotherleadersinHyderabad,Indiatoday.Initialt...npur,confirmedthatthemajorityofthedrinkingwaterava...doustohumanhealth. ,, Thetechnologydevelopedinc...
(Date:11/25/2009)...cBiotechLtd.(SVA),aleadingdeveloperandproviderofv...(JV)agreementtoestablishSinovac(Dalian)Vaccine,Tec...evelop,produce,andcommercializehuman-usevaccines.S...velopingandcommercializingworld-classvaccines;the,...acilitiesand,establishedoperatinginfrastructure. ,...
(Date:11/24/2009)...sit Detroit , (Vocus) Nov...bassador for International Investment, and Chairma...What: Ambassador Appia is available to meet with p...opted by France to further develop the financial, ...evelopment., , ,When: Available for Interview on W...
(Date:11/24/2009)...Sigma-AldrichCorporation(Nasdaq: SIAL )willbeprese...at1:45PMGMTinLondon,7:45AMUS/CST.Interestedparties...ableat http://inve s tor.sig m a a ldrich.c...e. ,, AboutSigma-Aldrich: Sigma-Aldrichisale...alandbiochemicalproductsandkitsareusedinscientific...
Breaking Biology Technology:North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3
...gressively Control Access to Biologics, ... WALTHAM, Mass., Sept. 10 Decision Resources, on...ms for pharmaceutical and,healthcare issues, finds...,in the course of treatment for psoriasis and psor...Payer Forum report entitled Psoriasis and Psoriati...
...dminister GAMMAGARD LIQUID(TM) 10% Could Make, Ho...t Up to $47 Million, DEERFIELD, Ill. and SAN DIEG... ) and Halozyme Therapeutics, Inc.,(Nasdaq: HALO ...ent to apply,Halozyme,s proprietary Enhanze(TM) Te...e of administration for Baxter,s GAMMAGARD LIQUID(...
... Pharmaceuticals,Inc. (Amex: ANX ) a biopharmaceu...commercializing proprietary product candidates for...announced today that it has received,confirmation ...egarding its,proposed 505(b)(2) New Drug Applicati...ulsion). The FDA has indicated that data from a si...
Other Biology Technology:Specialists Are Turning to Biologics Earlier in the Treatment of Psoriasis and Psoriatic Arthritis 2Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology 2Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology 3Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology 4Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology 5Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology 6Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology 7ADVENTRX Announces ANX-514 Clinical Development Plan Affirmed by the FDA 2ADVENTRX Announces ANX-514 Clinical Development Plan Affirmed by the FDA 3ADVENTRX Announces ANX-514 Clinical Development Plan Affirmed by the FDA 4
(Date:11/24/2009)...bridge, Md. (November 24, 2009) New research on b...iver ecosystems reveals predictable temporal patte...mmunities as markers for monitoring climate change...eek in the Proceedings of the National Academy of...munities in the six rivers shifted synchronously o...
(Date:11/23/2009)... Cambridge, Mass. November 23, 2009 Applied math...n lily ( Hosta lancifolia ), a characteristic long...y packed ripples along the edges. The simple cause...sulting from bending during differential growthwas...retching foam ribbons. , Haiyi Liang, a postdoct...
(Date:11/23/2009)...mington, CT Current research suggests that a comm...e. The related report by Nichols et al, "Unique L...w Class of TLR2 Ligands Capable of Enhancing Autoi...e American Journal of Pathology . , Multiple sc...tacks the brain and spinal cord, affects nearly 1 ...
Breaking Biology News(10 mins):Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2The cause behind the characteristic shape of a long leaf revealed 2Factors from common human bacteria may trigger multiple sclerosis 2Research vessel Polarstern starts 24th Arctic season 8898 1Research vessel Polarstern starts 24th Arctic season 8898 2UNH researcher receives presidential environmental award 8894 1UNH researcher receives presidential environmental award 8894 2Bioheart to Introduce Improved Heart Failure Monitoring Systems at Heart Failure Nurses Annual Meeting 49375 1Bioheart to Introduce Improved Heart Failure Monitoring Systems at Heart Failure Nurses Annual Meeting 49375 2Bioheart to Introduce Improved Heart Failure Monitoring Systems at Heart Failure Nurses Annual Meeting 49375 3
...f our daily vocabulary. We all know they,re part o...stas. We know they have something to do with starc... so familiar, there,s still a lot for science to l...es is still in its infancy," said Nikki Pohl, an I...try. Pohl said there,s more to learn about carbohy...
...rom UC Davis Cancer Center shows that a protein ca...ows breast cancer to spread to other organs and re...rs in the April 1 issue of Cancer Research , is o...n the disease. , Kermit Carraway, senior author o...ed in primary breast cancer tumors, yet it could b...
...n bringing together users and manufacturers of hig... the Cavimeter was judged by the panel to be "more...rd is the culmination of a period of research, dev...tegic Research funding in 1997. , Acoustic cavita...e of micron-sized bubbles in response to an applie...
Other Biology News:Iowa State chemist synthesizes carbohydrates, launches startup company 2UC Davis researchers identify a protein that may help breast cancer spread, beat cancer drugs 2NPL Cavimeter receives 2009 UIA Outstanding Product Award 2
... FAM-Labeled Substrate (green fluorescence; Ex=488...rotease activation • No lysing, fixing, or pe...e cell-permeable, fluorescently labeled inhibitors...sin-like activity in whole living cells. Select fr...
..., known as ChemiArrayTM Mouse Cytokine Antibody Ar...t methodologies. Besides the ability to detect pro...accurate reflection of active cytokine levels beca...plification step is needed. Furthermore, it is sim...
DNA Engine Thermal Cycler Chassis w/384-well block & motorized lid from Bio-Rad
...ay (MSTA) slides were designed to study protein ex...rom multiple species. Tissue slices from three di...ch can then be treated as a single histological sl... situ hybridization. This format allows a rapid ...
Biology Products: